VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $79 | -100.0% | 18,220 | -19.2% | 0.01% | -73.3% |
Q1 2022 | $255,000 | -53.1% | 22,541 | -35.0% | 0.03% | -50.0% |
Q4 2021 | $544,000 | +37.7% | 34,681 | +31.9% | 0.06% | +33.3% |
Q1 2021 | $395,000 | +237.6% | 26,293 | +132.9% | 0.04% | +95.7% |
Q1 2020 | $117,000 | -58.5% | 11,287 | -34.4% | 0.02% | -48.9% |
Q4 2019 | $282,000 | +59.3% | 17,193 | +29.1% | 0.04% | +45.2% |
Q3 2019 | $177,000 | -33.5% | 13,320 | -7.9% | 0.03% | -29.5% |
Q1 2019 | $266,000 | +9.9% | 14,457 | +0.9% | 0.04% | +22.2% |
Q1 2018 | $242,000 | -12.9% | 14,325 | -7.7% | 0.04% | -20.0% |
Q3 2017 | $278,000 | -17.0% | 15,521 | -24.3% | 0.04% | -28.6% |
Q2 2017 | $335,000 | +70.9% | 20,510 | +46.3% | 0.06% | +37.0% |
Q1 2017 | $196,000 | -22.8% | 14,023 | -8.2% | 0.05% | -32.4% |
Q3 2016 | $254,000 | -35.5% | 15,276 | -56.3% | 0.07% | -49.3% |
Q3 2015 | $394,000 | +162.7% | 34,928 | +196.0% | 0.13% | +157.7% |
Q2 2015 | $150,000 | – | 11,800 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |